Infectious complications in chronic kidney disease
Paquette A, Wang D, Jankowski M, Gutkowska J, Lavoie JM
I am not aware of any berberine trial comparable to LEADER or SELECT: large, multicenter, multi-year, and designed to test cardiovascular or mortality outcomes
Focus on smaller portions (6 to 22 ounce containers), prioritize protein at 25 to 35 grams per meal, and include a mix of cold and warm options since food preferences and tolerance can change day to day
While tirzepatide already exists as an incretin-based drug with superior weight loss outcomes, an oral formulation like orfoglipron could may increase treatment acceptability and adherence